Cranial Technologies Settles Patent Dispute with Ottobock on 3D Cranial Bands

Cranial Technologies Settles Patent Dispute with Ottobock

In a significant development for the cranial orthotic market, Cranial Technologies recently announced the resolution of its patent infringement litigation against Ottobock, a company involved in producing 3D cranial bands. The settlement marks the conclusion of legal disputes regarding the intellectual property rights essential to the technology used in these medical devices.

Effective immediately, Ottobock has agreed to withdraw its 3D cranial band from the market. Furthermore, they have committed to halting any further production or distribution of cranial orthotic devices for sale in the United States, including those utilizing 3D printing technology.

The terms of the settlement include a confidential financial agreement, where Ottobock will pay Cranial Technologies based on the volume of cranial bands sold since the product's introduction. Cranial Technologies emphasized its dedication to safeguarding its innovations in the pediatric healthcare sector and reaffirmed its commitment to taking necessary actions to defend its patents.

Founded more than four decades ago, Cranial Technologies has built a renowned reputation in treating infants with plagiocephaly, commonly known as flat head syndrome. The company utilizes the DOC Band®, a specialized cranial remolding orthosis, to help in the healthy development of children's skulls. With over 100 operational clinics across the United States, Europe, and China, Cranial Technologies has supported more than 500,000 infants and continues to advance the standard of care in this field.

In addition to its established practices, Cranial Technologies has also expanded its offerings to include the EarWell® Infant Ear Molding System, aimed at addressing ear deformities in infants. This strategic development further proves their relentless pursuit of innovative solutions for pediatric care.

Cranial Technologies prides itself on its expert clinical teams and evidence-based treatment protocols, ensuring that families receive the highest quality care available. As the company moves forward after this legal victory, it aims to continue enhancing its services and outcomes for all babies needing cranial support.

With this legal matter now settled, both companies can focus on their respective objectives, paving the way for Cranial Technologies to further its mission of improving infant healthcare and fostering innovation in cranial treatment technologies.